
Professor PharmDr. Petr Pavek, PhD
Petr is focuses on gene regulation of xenobiotic-metabolizing and on molecular pharmacology on novel NRs ligands.

PharmDr. Ondřej Holas, PhD
Ondřej is working on nanoformulations of nuclear receptors ligands for liver or intestinal therapy.

Professor PharmDr. František Trejtnar, Ph.D
František is involved in radiopharmacy research and diagnostics and in pharmacokinetics and renal pharmacology.

Associate Professor Tomáš Smutný, PharmDr., PhD
His research interest is focused on hepatic cellular models including 3D spheroids of primary human hepatocytes.

Associate Professor Pavel Bárta, PhD
Pavel is radiobiologist.
PharmDr. Martin Ambrož, PhD
Martin is developing novel therapies based on novel NR ligands.
Jana Maixnerova, RNDr., PhD., junior researcher
Jana is working on different aspect of toxicity testing.
Alžbeta Horvátová, MSc., junior researcher
“Sisi” is focused on the treatment of liver diseases with new steroidal NRs ligands.
PharmDr. Barbora Boltnarová, MSc.
Barbora is focused on biodegradable nanoformulations based on ligands for the treatment of inflammatory diseases.
Michael Bakker, PhD
Michael is a bioinformation person doing a lot of simulations.
Nancy Mrózková, MSc.
Nancy is focused on novel lipid and polymer nanoformulations for oral and targeted drug delivery.
Mária Bajnoková
Maria is working on application of novel ligands in therapeutick applications.
Rajamnikkam Kamaraj, MSc.
Raja is doing in silico and in vitro testing of novel ligands
Dharani Sai Sreekanth Nellore
Sree is involved in examination novel CAR ligands in hepatic models
Petra Grosová, MSc.
Petra works on novel nanoformulation for the treatment intracellular infections
Nikta Mehdizadeh
Nikta is working on radiopeptides targeting tumors.